# Transcriptomic analysis of differential expression between surviving and nonsurviving patients infected by the SARS-CoV-2 Delta variant

**Authors:** Ivan Vlasov, Tatiana Usenko, Alexandra Panteleeva, Mikhail Nikolaev, Artem Izumchenko, Valeriia Panafidina, Elena Gavrilova, Irina Shlyk, Valentina Miroshnikova, Yurii Polushin, Maria Shadrina, Sofya Pchelina, Petr Slominsky

PMC · DOI: 10.1038/s41598-025-00280-3 · Scientific Reports · 2025-05-15

## TL;DR

This study identifies genes linked to survival in severe Delta variant COVID-19 patients by analyzing blood cell RNA.

## Contribution

The study identifies specific genes associated with survival in severe Delta variant COVID-19 patients.

## Key findings

- Differentially expressed genes in PBMCs distinguish survivors from nonsurvivors in severe Delta variant cases.
- Genes like ISG15, C1QB, and SERPING1 are upregulated in survivors and linked to immune and antiviral responses.
- ISG15 is highlighted as a key gene involved in multiple gene ontology clusters and antiviral mechanisms.

## Abstract

For a more precise understanding of the course of the pathological process in patients with severe COVID-19, it is necessary to continue the search for factors that affect the course of the pathological process and the possibility of a favorable outcome in critically ill patients. Comparative RNA-seq analysis of the transcriptome of peripheral blood mononuclear cell (PBMCs) in patients with a severe clinical course of COVID-19 caused by the SARS-CoV-2 Delta strain revealed a number of differentially expressed genes that distinguish patients with different clinical outcomes (survivors vs. nonsurvivors) in the period of 30 days after admission to the hospital. Most of them are associated with the “negative regulation of viral process” and “negative regulation of immune response” clusters. Moreover, in surviving patients, there is increased expression of the key genes C1QB, C1QA, ISG15, SERPING1, VSIG4, KLRD1, TRPM4, and HFE incorporated in these clusters. Among these key genes, the ISG15 gene, which links several clusters of gene ontology enrichments and encodes an interferon-induced ubiquitin-like protein, deserves special attention. Its product, ISG15, is known to be a primary substrate for SARS-CoV-2 protease PLpro, which plays a role in counteracting hosts’ antiviral mechanisms.

The online version contains supplementary material available at 10.1038/s41598-025-00280-3.

## Linked entities

- **Genes:** C1QB (complement C1q B chain) [NCBI Gene 713], C1QA (complement C1q A chain) [NCBI Gene 712], ISG15 (ISG15 ubiquitin like modifier) [NCBI Gene 9636], SERPING1 (serpin family G member 1) [NCBI Gene 710], VSIG4 (V-set and immunoglobulin domain containing 4) [NCBI Gene 11326], KLRD1 (killer cell lectin like receptor D1) [NCBI Gene 3824], TRPM4 (transient receptor potential cation channel subfamily M member 4) [NCBI Gene 54795], HFE (homeostatic iron regulator) [NCBI Gene 3077]
- **Diseases:** COVID-19 (MONDO:0100096)

## Full-text entities

- **Genes:** IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, IRF3 (interferon regulatory factor 3) [NCBI Gene 3661] {aka IIAE7}, TRPM4 (transient receptor potential cation channel subfamily M member 4) [NCBI Gene 54795] {aka EKVP6, LTrpC4, PFHB1B, TRPM4B, hTRPM4}, KLRD1 (killer cell lectin like receptor D1) [NCBI Gene 3824] {aka CD94}, IFI44L (interferon induced protein 44 like) [NCBI Gene 10964] {aka C1orf29, GS3686, TLDC5B}, DEFA3 (defensin alpha 3) [NCBI Gene 1668] {aka DEF3, HNP-3, HNP3, HP-3, HP3}, ISG15 (ISG15 ubiquitin like modifier) [NCBI Gene 9636] {aka G1P2, IFI15, IMD38, IP17, UCRP, hUCRP}, LYZ (lysozyme) [NCBI Gene 4069] {aka AMYLD5, LYZF1, LZM}, IFIH1 (interferon induced with helicase C domain 1) [NCBI Gene 64135] {aka AGS7, Hlcd, IDDM19, IMD95, MDA-5, MDA5}, IL27 (interleukin 27) [NCBI Gene 246778] {aka IL-27, IL-27A, IL27A, IL27p28, IL30, p28}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, SERPING1 (serpin family G member 1) [NCBI Gene 710] {aka C1IN, C1INH, C1NH, HAE1, HAE2}, RIT2 (Ras like without CAAX 2) [NCBI Gene 6014] {aka RIBA, RIN, ROC2}, FLNB (filamin B) [NCBI Gene 2317] {aka ABP-278, ABP-280, FH1, FLN-B, FLN1L, LRS1}, C1QA (complement C1q A chain) [NCBI Gene 712] {aka C1QD1}, C3 (complement C3) [NCBI Gene 718] {aka AHUS5, ARMD9, ASP, C3a, C3b, CPAMD1}, IFNB1 (interferon beta 1) [NCBI Gene 3456] {aka IFB, IFF, IFN-beta, IFNB}, TTR (transthyretin) [NCBI Gene 7276] {aka AMYLD1, ATTR, CTS, CTS1, HEL111, HsT2651}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, ITGAL (integrin subunit alpha L) [NCBI Gene 3683] {aka CD11A, EV6, HNA-5, LFA-1, LFA1A}, IFITM3 (interferon induced transmembrane protein 3) [NCBI Gene 10410] {aka 1-8U, DSPA2b, IP15}, C1QB (complement C1q B chain) [NCBI Gene 713] {aka C1QD2}, VSIG4 (V-set and immunoglobulin domain containing 4) [NCBI Gene 11326] {aka CRIg, Z39IG}, ACE2 (angiotensin converting enzyme 2) [NCBI Gene 59272] {aka ACEH}, VTN (vitronectin) [NCBI Gene 7448] {aka V75, VN, VNT}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, HFE (homeostatic iron regulator) [NCBI Gene 3077] {aka HFE1, HH, HLA-H, MVCD7, TFQTL2}, MASP1 (MBL associated serine protease 1) [NCBI Gene 5648] {aka 3MC1, CRARF, CRARF1, MAP-1, MAP1, MASP}, C1R (complement C1r) [NCBI Gene 715] {aka EDS8, EDSPD1}, IFI6 (interferon alpha inducible protein 6) [NCBI Gene 2537] {aka 6-16, FAM14C, G1P3, IFI-6-16, IFI616}
- **Diseases:** inflammation (MESH:D007249), Pipeline 2 (MESH:D020803), viremia (MESH:D014766), deaths (MESH:D003643), respiratory failure (MESH:D012131), ARDS (MESH:D012128), cancer (MESH:D009369), infectious diseases (MESH:D003141), infected (MESH:D007239), heart failure (MESH:D006333), pneumonia (MESH:D011014), COVID-19 (MESH:D000086382), severe (MESH:D045169), hereditary angioedema (MESH:D054179), muscle (MESH:D019042), cerebrovascular diseases (MESH:D002561), angioedema (MESH:D000799), lung cancer (MESH:D008175), renal failure (MESH:D051437), chronic obstructive pulmonary disease (MESH:D029424)
- **Chemicals:** PBS (MESH:D007854), lipopolysaccharide (MESH:D008070), EDTA (MESH:D004492), all-trans-retinoic acid (MESH:D014212), polyA (MESH:D011061), TRIzol Reagent (-)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Influenza B virus (no rank) [taxon 11520], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Human papillomavirus (species) [taxon 10566], Severe acute respiratory syndrome-related coronavirus (no rank) [taxon 694009], Middle East respiratory syndrome-related coronavirus (no rank) [taxon 1335626], Deltacoronavirus (genus) [taxon 1159901], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** D614G, T478 K, D1118H, L452R, S A, P681R, T19R, T716I, P681H, S982 A, rs78958998, D950 N, N501Y, G142D, A570D
- **Cell lines:** Pipeline 1 — Mus musculus (Mouse), Hybridoma (CVCL_C7RB)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12081745/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12081745/full.md

## References

68 references — full list in the complete paper: https://tomesphere.com/paper/PMC12081745/full.md

---
Source: https://tomesphere.com/paper/PMC12081745